Incyte (INCY) Debt Ratio (2012 - 2026)

Incyte (INCY) reported Debt Ratio of 0.01 for Q1 2026, down 26.04% on a YoY basis from 0.01 in Q1 2025, and down 9.25% quarter-over-quarter from 0.01 in Q4 2025.

Incyte (INCY) Debt Ratio (2012 - 2026) Analysis & Trends

Incyte has reported Debt Ratio for 14 years, with the latest figure at 0.01 in Q1 2026.

  • For the quarter ending Q1 2026, Debt Ratio fell 26.04% year-over-year to 0.01; the trailing twelve-month figure through Mar 2026 stood at 0.01 (down 26.04% YoY), and the FY2025 full-year result was 0.01, down 17.95% from the prior year.
  • Debt Ratio for Q1 2026 stood at 0.01, down from 0.01 in the prior quarter.
  • The five-year high for Debt Ratio was 0.01 in Q3 2024, with the low at 0.01 in Q1 2024.
  • Historically, Debt Ratio has averaged 0.01 across 5 years, with a median of 0.01 in 2023.
  • Annual changes were most pronounced in 2022 — Debt Ratio tumbled 32.23% — and 2024, when it soared 39.63%.
  • Incyte's Debt Ratio stood at 0.01 in 2022, then retreated by 9.44% to 0.01 in 2023, then increased by 27.22% to 0.01 in 2024, then dropped by 17.95% to 0.01 in 2025, then declined by 9.25% to 0.01 in 2026.
  • The last three Debt Ratio figures came in at 0.01 (Q1 2026), 0.01 (Q4 2025), and 0.01 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.18
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn 0.01

Historic Data

Download Data
DateValue
Mar 31, 2026 0.01
Dec 31, 2025 0.01
Sep 30, 2025 0.01
Jun 30, 2025 0.01
Mar 31, 2025 0.01
Dec 31, 2024 0.01
Sep 30, 2024 0.01
Jun 30, 2024 0.01
Mar 31, 2024 0.01
Dec 31, 2023 0.01
Sep 30, 2023 0.01
Jun 30, 2023 0.01
Mar 31, 2023 0.01
Dec 31, 2022 0.01
Sep 30, 2022 0.01
Jun 30, 2022 0.01
Mar 31, 2022 0.01
Dec 31, 2021 0.01
Sep 30, 2021 0.01
Jun 30, 2021 0.01